Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Determinants of transmission-blocking properties of antibodies targeting the 6C domain of Pfs48/45 of the Plasmodium falciparum parasite

EF 2021-22

Résumé
Over 400,000 people die from malaria each year ; most of these resulting from infection by the Plasmodium falciparum parasite. Although the very first Malaria vaccine has been recently approved by the World Health Organization, it fails to provide long-term immunity as protection against the parasite wanes rapidly over time. This highlights the need for the development of alternative malaria vaccines that confers long-term protective immunity. One promising vaccine candidate involves immunization of individuals with a Pfs48/45 antigen (6C); a protein expressed on P. falciparum during sexual reproduction of the parasite. Immunization through this antigen induces the generation of highly potent antibodies that block transmission of the parasite to humans. However, less potent antibodies are generated as well. The generation of these low potent antibodies is problematic as it can hinder the overall immune response, confer lower levels of protection from the parasite, and result in poor efficacy of the vaccine. The production of low potency antibodies can be avoided by modifying the structure of the antigen. However, where and what types of modifications are required can only be inferred by having a molecular understanding of how these low potency antibodies interact with the antigen. Using biochemical techniques, I aim to determine the strength, speed, and location these low potency antibodies bind to the antigen. These molecular insights are critical for guiding the development of a highly effective malaria vaccine ; an important steppingstone in the eradication of malaria.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
466665
Name
Yoo Randy
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Determinants of transmission-blocking properties of antibodies targeting the 6C domain of Pfs48/45 of the Plasmodium falciparum parasite
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibody; Biochemistry; Malaria; Plasmodium Falciparum; Structural Biology; Vaccine
Abstract
Over 400,000 people die from malaria each year ; most of these resulting from infection by the Plasmodium falciparum parasite. Although the very first Malaria vaccine has been recently approved by the World Health Organization, it fails to provide long-term immunity as protection against the parasite wanes rapidly over time. This highlights the need for the development of alternative malaria vaccines that confers long-term protective immunity. One promising vaccine candidate involves immunization of individuals with a Pfs48/45 antigen (6C); a protein expressed on P. falciparum during sexual reproduction of the parasite. Immunization through this antigen induces the generation of highly potent antibodies that block transmission of the parasite to humans. However, less potent antibodies are generated as well. The generation of these low potent antibodies is problematic as it can hinder the overall immune response, confer lower levels of protection from the parasite, and result in poor efficacy of the vaccine. The production of low potency antibodies can be avoided by modifying the structure of the antigen. However, where and what types of modifications are required can only be inferred by having a molecular understanding of how these low potency antibodies interact with the antigen. Using biochemical techniques, I aim to determine the strength, speed, and location these low potency antibodies bind to the antigen. These molecular insights are critical for guiding the development of a highly effective malaria vaccine ; an important steppingstone in the eradication of malaria.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yoo, Randy
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~